March 14 (Reuters) - Leap Therapeutics Inc:
* LEAP THERAPEUTICS PROVIDES DKN-01 PROGRAM UPDATE AND ANNOUNCES SCIENTIFIC PRESENTATIONS AT AACR ANNUAL MEETING
* LEAP THERAPEUTICS INC - FIRST PATIENT HAS BEEN ENROLLED IN STUDY EVALUATING DKN-01 IN PATIENTS WITH GYNECOLOGICAL CANCERS Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)
Our Standards: The Thomson Reuters Trust Principles.